San Diego, CA30+ days ago
In addition, the company is currently developing the G4X Spatial Sequencer, an upgrade to the G4, which will leverage Singular's proprietary sequencing technology, applying it as an in situ readout for transcriptomics, proteomics and fluorescent H&E in tissue, with spatial context. This leader will unify digital, brand/creative, events, and product marketing to drive awareness, generate demand, and support adoption across biopharma, academic, and translational research customers.